Archit Organosys board withdrew agenda items concerning acquisition and share capital restructuring Back
<p>Archit Organosys Limited informed the BSE Limited that its board withdrew agenda items related to an increase in authorized share capital, the acquisition of up to 1,36,24,172 equity shares, representing 67.44% of the Equity Share Capital of Archit Life Science Limited, and a preferential allotment of equity shares, citing a restructuring of the proposed transaction.</p>